Endocrine disruptor to have committed scientific misconduct. Found in many household and industrial products, endocrine disruptors are substances that "interfere with the synthesis, secretion, transport, binding, action, or elimination of natural hormones in the body that are responsible for development, behavior, fertility, and maintenance of homeostasis (normal cell metabolism)." They are sometimes also referred to as hormonally active agents, endocrine disrupting chemicals, or endocrine disrupting compounds. The variety of terms used to describe these substances reflects not only a range of meanings but a range of connotations, with "endocrine disruptor" emphasizing harmful effects, while "hormonally active agent" or "xenohormone" are more neutral,
Multiple endocrine neoplasia type 2b Multiple endocrine neoplasia type 2b Multiple endocrine neoplasia type 2B (also known as "MEN2B", "Mucosal neuromata with endocrine tumors", "Multiple endocrine neoplasia type 3", and "Wagenmann–Froboese syndrome") is a genetic disease that causes multiple tumors on the mouth, eyes, and endocrine glands. It is the most severe type of multiple endocrine neoplasia, differentiated by the presence of benign oral and submucosal tumors in addition to endocrine malignancies. It was first described by Wagenmann in 1922, and was first recognized as a syndrome in 1965-1966 by E.D. Williams and D.J. Pollock. MEN 2B typically manifests before a child is 10 years